Analyst firms · Citigroup · TNDM
Citigroup TNDM price target and rating history
Tandem Diabetes Care Inc. (TNDM) · Health Care
Citigroup rates Tandem Diabetes Care Inc. (TNDM) Neutral with a $20 price target, as of its latest action on Sep 30, 2026. It has published 7 rating actions on TNDM since February 2022, including 2 upgrades and 3 downgrades. Across 11 firms with a TNDM price target in the last 12 months, the median target is $27. Citigroup's $20 is 26% below that.
- Current rating
- Neutral
- Price target
- $20
- Median target, all firms
- $27
- Actions on TNDM
- 7
Citigroup price target on TNDM
Every Citigroup rating on TNDM
- Sep 30, 2026
- Aug 12, 2025
- Jul 9, 2025
- Mar 4, 2025
- May 22, 2024
- Aug 4, 2023
- Feb 23, 2022
How other firms rate TNDM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $18 | Oct 7, 2026 |
| Citigroup | Neutral | $20 | Sep 30, 2026 |
| William Blair | Outperform | Aug 21, 2026 | |
| UBS | Neutral | $18 | Jul 28, 2026 |
| Deutsche Bank | Hold | $15.50 | Jun 23, 2026 |
| Wells Fargo | Overweight | $27 | Jun 1, 2026 |
| The Benchmark Company | Hold | May 12, 2026 | |
| Truist Securities | Buy | $35 | Mar 19, 2026 |
| Piper Sandler | Overweight | $33 | Mar 17, 2026 |
| Lake Street | Buy | $50 | Feb 23, 2026 |
| BofA Securities | Neutral | $30 | Feb 20, 2026 |
| TD Cowen | Buy | $25 | Jan 27, 2026 |
| Robert W. Baird | Outperform | $30 | Dec 16, 2025 |
Questions about Citigroup and TNDM
- What is Citigroup's price target for TNDM?
- Citigroup's latest stated price target for Tandem Diabetes Care Inc. (TNDM) is $20, from its action on Sep 30, 2026.
- What is Citigroup's rating on TNDM?
- Citigroup rates TNDM Neutral, a neutral rating, as of Sep 30, 2026.
- When did Citigroup last change its view on TNDM?
- On Sep 30, 2026, Citigroup cuts its price target to $20 from $24, keeps Neutral.
- How does Citigroup's TNDM target compare with other analysts?
- Across 11 firms with a TNDM price target in the last 12 months, the median target is $27. Citigroup's $20 is 26% below that.
More TNDM rating histories
All Citigroup ratingsTNDM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.